These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 20735414)

  • 21. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of EDG receptors and lysophospholipids as their endogenous ligands in the respiratory tract.
    Racké K; Hammermann R; Juergens UR
    Pulm Pharmacol Ther; 2000; 13(3):99-114. PubMed ID: 10873548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lysophosphatidic acid and malignant neoplasms].
    Jesionowska A; Cecerska-Heryć E; Marczuk N; Safranow K; Dołęgowska B
    Postepy Biochem; 2015; 61(4):381-7. PubMed ID: 27048092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of lysophosphatidic acid analogs.
    Lynch KR; Macdonald TL
    Biochim Biophys Acta; 2002 May; 1582(1-3):289-94. PubMed ID: 12069840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
    Peyruchaud O
    Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
    Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
    J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.
    Xu J; Lai YJ; Lin WC; Lin FT
    J Biol Chem; 2004 Mar; 279(11):10459-68. PubMed ID: 14688263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K; Ishii S; Shimizu T
    J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers.
    Yaginuma S; Omi J; Kano K; Aoki J
    Pharmacol Ther; 2023 Jun; 246():108415. PubMed ID: 37061204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging role of lysophosphatidic acid in cancer.
    Mills GB; Moolenaar WH
    Nat Rev Cancer; 2003 Aug; 3(8):582-91. PubMed ID: 12894246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Edg family LPA receptors: the cutting edge of LPA research.
    Yanagida K; Ishii S
    J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological responses to lysophosphatidic acid and related glycero-phospholipids.
    Tigyi G
    Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):47-62. PubMed ID: 11324707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
    McIntyre TM; Pontsler AV; Silva AR; St Hilaire A; Xu Y; Hinshaw JC; Zimmerman GA; Hama K; Aoki J; Arai H; Prestwich GD
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):131-6. PubMed ID: 12502787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysophosphatidic Acid Signaling in Diabetic Nephropathy.
    Lee JH; Kim D; Oh YS; Jun HS
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.